Our PV RBC proteome analysis using mass spectrometry showed higher ABCG2 levels in PV RBCs compared to RBCs from healthy controls [11] and an additional increase of these levels in PV patients treated with HU [12], suggesting that ABCG2 might play a role in multidrug resistance in MPNs. Here, ABCG2 is linked to acquired polycythemia vera.